The Dream That Collided with Math
Clearwater Paper loves to tell you it’s the independent giant killer of North American paperboard. The numbers sound heroic: 14% share of a 10 million-ton market, the #3 producer, focused on the glossy, premium world of SBS (solid bleached sulfate) cartons that wrap your cereal and coffee pods.
The model is simple:
- At 90–95% utilization, they claim margins of 13–14% on EBITDA and free cash flow of over $100 million a year.
- At peak (>95% utilization), they pencil in 16% EBITDA margins with 50–60% cash conversion.
- That’s the fantasy.
But here’s the hangover: Q2 2025 industry utilization wasn’t 95%. It wasn’t 90%. It wasn’t even 85%. It limped in at 83%.
And Clearwater knows the difference between 83% and 93% isn’t abstract. Every turn lower slices tens of millions from EBITDA, pushes fixed costs into the red, and keeps their “cycle math” looking more like a fairy tale than a forecast.
The Big Shrug: “Mixed Signals”
On the July call, Clearwater executives tried to downplay the shortfall: their own shipments rose 5% sequentially, backlogs even grew 14% QoQ, and yet the industry’s engine coughed. SBS shipments across North America fell 3% from Q1 to Q2, and operating rates ticked down from 84% in Q2 2024 to 83% in Q2 2025.
What happened to the recovery? The easy scapegoats:
- New capacity added by a competitor in Q2.
- Imports that stubbornly refuse to shrink despite tariffs and an unfavorable dollar.
- The kind of “near-term economic uncertainty” that executives invoke when they don’t have a clean answer.
It all adds up to a company that sounds faintly surprised that the market isn’t behaving as their spreadsheets promised.
The Knife Edge of Leverage
The financials paint the story:
- Q2 net sales: $392M (+12% YoY, thanks to the Augusta acquisition).
- Adj. EBITDA: $40M, a 10% margin—middle of guidance but light years from their 13–14% cycle target.
- Q3 guidance: a limp $10–20M of EBITDA, weighed down by a $23–25M Lewiston outage and 5% lower volumes from lost absorption.
Their own investor deck shows the knife-edge:
- A 100,000-ton increase in sales would add $50M in contribution margin.
- A $50/ton price lift would pump $60M into EBITDA.
That’s the leverage they brag about. But when utilization sits in the low-80s, that same leverage works in reverse.
Cost Cuts Can’t Mask Capacity Bloat
Clearwater is cutting fat where it can:
- $30–40M of fixed cost reduction in 2025, annualized to $40–50M in savings.
- SG&A trimmed to 6.7% of net sales, down from 8.8% last year.
- Net leverage ratio: 1.9x, leaving them with financial breathing room.
But cost cuts don’t solve the problem of too many tons chasing too few boxes. The Augusta acquisition bulked up volumes, but industry-wide supply additions more than erased Clearwater’s gain.
The Blind Spot: Faith in Cycles
Clearwater insists this is temporary. They wave around RISI’s forecast that 350,000 tons of SBS capacity will exit in 2026, enough to nudge utilization back toward the golden 90% zone. They frame 2025 as the valley in a classic cycle, not the beginning of a structural glut.
But here’s the rub:
- Imports are forecast to decrease only ~4% in 2025, while exports dip 2%. That’s hardly the dramatic tightening Clearwater is counting on.
- Demand growth? Just 3% projected for 2026—not exactly a boom.
They’re right that cycles matter. But their surprise at today’s 83% utilization suggests they underestimated just how sticky oversupply can be.